Effects of poloxamer 407 on the assembly, structure and dissolution of fibrin clots

Blood Coagulation and Fibrinolysis

Volumn 7, Issue 2, 1996, Pages 109-113

  Carr Jr , M E ^a,b   Carr, S L ^a   High, A A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HUNTER HOLMES MCGUIRE VA MEDICAL CENTER   (United States)

Author keywords

Fibrinolysis; Plasma; Plasminogen; Tissue plasminogen activator

Indexed keywords

ALTEPLASE; FLOWGEL; PLASMINOGEN; POLOXAMER; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; FIBRIN CLOT; FIBRINOLYSIS; HUMAN; PLASMA; PRIORITY JOURNAL; THROMBOCYTE;

EID: 0029954736     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199603000-00001     Document Type: Article

References (36)

1. Ferry JD, Morrison PR. Preparation and properties of serum and plasma proteins. VIII. The conversion of human fibrinogen to fibrin under various conditions. J Am Chem Soc 1947; 69: 388-399.
2. Shulman S, Ferry JD, Tinoco I. The conversion of fibrinogen to fibrin. XII. Influence of pH, ionic strength and hexamethylene glycol concentration on the polymerization of fibrinogen. Arch Biochem Biophys 1953; 42: 245-256.
3. Gabriel DA, Smith LA, Folds JD, Davis L, Cancelosi SE. The influence of immunoglobulin (IgG) on the assembly of fibrin gels. J Lab Clin Med 1983; 101: 545-552.
4. Bale MD, Westrick LG, Mosher DF. Incorporation of thrombospondin into fibrin clots. J Biol Chem 1985; 260: 7502-7508.
5. Carr ME. Turbidimetric evaluation of albumin's impact on the structure of thrombin mediated fibrin gels. Haemostasis 1987; 17: 189-194.
6. Carr ME, Gabriel DA, McDonagh J. Influence of factor XIII and fibronectin on fiber size in thrombin-induced fibrin gels. J Lab Clin Med 1987; 110: 747-752.
7. Carr ME, Gabriel DA, Herion JC, Roberts HR. Granulocyte lysosomal cationic protein alters fibrin assembly: a possible mechanism for granulocyte control of clot structure. J Lab Clin Med 1986; 107: 199-203.
8. Carr ME, White GC, Gabriel DA. Platelet factor 4 enhances fibrin fiber polymerization. Thromb Res 1987; 45: 539-543.
9. LeBoeuf RD, Gregg RR, Weigel PH, Fuller GM. Effects of hyaluronic acid and other glycosaminoglycans on fibrin polymer formation. Biochemistry 1987; 26: 6052-6057.
10. Jones M, Gabriel DA. Influence of the subendothelial basement membrane components on fibrin assembly. Evidence for a fibrin binding site on Type IV collagen. J Biol Chem 1988; 263: 7043-7048.
11. Carr ME, Powers PL. Effect of glycosaminoglycans on thrombin- and atroxin-induced fibrin assembly and structure. Thromb Haemost 1989; 62: 1057-1061.
12. Carr ME, Gabriel DA, McDonagh J. Influence of calcium on the structure of reptilase and thrombin derived fibrin gels. Biochem J 1986; 239: 513-516.
13. Shen LL, Hermans J, McDonagh J, McDonagh RP, Carr ME. Effects of calcium ion and covalent crosslinking on formation and elasticity of fibrin gels. Thromb Res 1975; 6: 255-265.
14. Marx G. Divalent cations induce protofibril gelation. Am J Hematol 1988; 27: 104-109.
15. Carr ME, Gabriel DA. The effect of dextran 70 on the structure of plasma-derived fibrin gels. J Lab Clin Med 1980; 96: 985-993.
16. Carr ME, Gabriel DA. Dextran-induced changes in fibrin fiber size and density based on wavelength dependence of gel turbidity. Macromolecules 1980; 13: 1473-1477.
17. Carr ME. The effect of hydroxyethyl starch on the structure of thrombin and reptilase induced fibrin gels. J Lab Clin Med 1986; 108: 556-563.
18. Gabriel DA, Muga K, Boothroyd EM. The effect of fibrin structure on fibrinolysis. J Biol Chem 1992; 267: 24259-24263.
19. Collet J, Soria J, Mirshahi M, et al. Dusart syndrome: a new concept of the relationship between fibrin clot architecture and fibrin clot degradability: hypofibrinolysis related to an abnormal clot structure. Blood 1993; 82: 2462-2469.
20. Carr ME, Alving BM. Effect of fibrin structure on plasmin-mediated dissolution of plasma clots. Blood Coag Fibrinol 1995; 6: 567-573.
21. Carr ME, Powers PL, Jones M. Effects of poloxamer 188 on the assembly, structure and dissolution of fibrin clots. Thromb Haemost 1991; 66: 565-568.
22. Porter CJ, Moghimi SM, Illum L, Davis SS. The polyoxyethylene/polyoxypropylene block co-polymer poloxamer-407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow. FEBS Lett 1992; 305: 62-66.
23. Juhasz J, Lenaerts V, Raymond P, Ong H. Diffusion of rat atrial natriuretic factor in thermoreversible poloxamer gels. Biomaterials 1989; 10: 265-268.
24. Leach RE, Henry RL. Reduction of postoperative adhesions in the rat uterine horn model with poloxamer 407. Am J Obstet Gynecol 1990; 162: 1317-1319.
25. Steinleitner A, Lambert H, Kazensky C, Cantor B. Poloxamer 407 as an intraperitoneal barrier material for the prevention of postsurgical adhesion formation and reformation in rodent models for reproductive surgery. Obstet Gynecol 1991; 77: 48-52.
26. Rice VM, Shanti A, Moghissi KS, Leach RE. A comparative evaluation of poloxamer 407 and oxidized regenerated cellulose (Interceed [TC7]) to reduce postoperative adhesion formation in the rat uterine horn model. Fertil Steril 1993; 59: 901-906.
27. Reigel DH, Bazmi B, Shih SR, Marquardt MD. A pilot investigation of poloxamer 407 for the prevention of leptomeningeal adhesions in the rabbit. Pediatr Neurosurg 1993; 19: 250-255.
28. Laki K. The polymerization of proteins: the action of thrombin on fibrinogen. Arch Biochem Biophys 1951; 32: 317-324.
29. Clauss A. A rapid physiological coagulation method for determination of fibrinogen. Acta Haematol 1957; 17: 237-246.
30. Carr ME, Krishnamurti C, Alving BM. Effect of plasminogen activator inhibitor type 1 on tissue-type plasminogen activator-induced fibrinolysis. Thromb Haemost 1992; 67: 106-110.
31. Carr ME, Shen LL, Hermans J. Mass-length ratio of fibrin fibers from gel permeation and light scattering. Biopolymers 1977; 16: 1-15.
32. Carr ME. Fibrin formed in plasma is composed of fibers more massive than those formed from purified fibrinogen. Thromb Haemost 1988; 59: 535-539.
33. Carr ME, Hardin CL. Fibrin has larger pores when formed in the presence of erythrocytes. Am J Physiol 1987; 253: H1069-H1073.
34. Carr ME, Hauge Y. Enhancement of erythrocyte washout from blood clots by pharmacologic manipulation of gel pore size and erythrocyte flexibility. Am J Physiol 1990; 259: H1527-H1532.
35. Ciano PS, Colvin RB, Dvorak AM, McDonagh J, Dvorak HF. Macrophage migration in fibrin gel matrices. Lab Invest 1986; 54: 62-70.
36. Lanir N, Ciano PS, Van de Water L, McDonagh J, Dvorak AM, Dvorak HF. Macrophage migration in fibrin gel matrices. II. Effects of clotting factor XIII, fibronectin, and glycosaminoglycan content on cell migration. J Immunol 1988; 140: 2340-2349.